These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24726695)

  • 1. Results of the 4th scientific workshop of the ECCO (Group II): markers of intestinal fibrosis in inflammatory bowel disease.
    Rieder F; de Bruyn JR; Pham BT; Katsanos K; Annese V; Higgins PD; Magro F; Dotan I
    J Crohns Colitis; 2014 Oct; 8(10):1166-78. PubMed ID: 24726695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of the 4th scientific workshop of the ECCO (I): pathophysiology of intestinal fibrosis in IBD.
    Latella G; Rogler G; Bamias G; Breynaert C; Florholmen J; Pellino G; Reif S; Speca S; Lawrance IC
    J Crohns Colitis; 2014 Oct; 8(10):1147-65. PubMed ID: 24731838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of the Fifth Scientific Workshop of the ECCO (II): Pathophysiology of Perianal Fistulizing Disease.
    Siegmund B; Feakins RM; Barmias G; Ludvig JC; Teixeira FV; Rogler G; Scharl M
    J Crohns Colitis; 2016 Apr; 10(4):377-86. PubMed ID: 26681764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European Crohn's and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn's Disease.
    Rieder F; Latella G; Magro F; Yuksel ES; Higgins PD; Di Sabatino A; de Bruyn JR; Rimola J; Brito J; Bettenworth D; van Assche G; Bemelman W; d'Hoore A; Pellino G; Dignass AU
    J Crohns Colitis; 2016 Aug; 10(8):873-85. PubMed ID: 26928961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Modalities for Inflammatory Bowel Disease: Serologic Markers and Endoscopy.
    Clark C; Turner J
    Surg Clin North Am; 2015 Dec; 95(6):1123-41, v. PubMed ID: 26596918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of the 2nd part Scientific Workshop of the ECCO. II: Measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease.
    Daperno M; Castiglione F; de Ridder L; Dotan I; Färkkilä M; Florholmen J; Fraser G; Fries W; Hebuterne X; Lakatos PL; Panés J; Rimola J; Louis E;
    J Crohns Colitis; 2011 Oct; 5(5):484-98. PubMed ID: 21939926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.
    Bourreille A; Ignjatovic A; Aabakken L; Loftus EV; Eliakim R; Pennazio M; Bouhnik Y; Seidman E; Keuchel M; Albert JG; Ardizzone S; Bar-Meir S; Bisschops R; Despott EJ; Fortun PF; Heuschkel R; Kammermeier J; Leighton JA; Mantzaris GJ; Moussata D; Lo S; Paulsen V; Panés J; Radford-Smith G; Reinisch W; Rondonotti E; Sanders DS; Swoger JM; Yamamoto H; Travis S; Colombel JF; Van Gossum A;
    Endoscopy; 2009 Jul; 41(7):618-37. PubMed ID: 19588292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can we prevent, reduce or reverse intestinal fibrosis in IBD?
    Latella G; Sferra R; Speca S; Vetuschi A; Gaudio E
    Eur Rev Med Pharmacol Sci; 2013 May; 17(10):1283-304. PubMed ID: 23740440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory Bowel Disease.
    Prog Drug Res; 2016; 71():117-22. PubMed ID: 26939275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of the 2nd scientific workshop of the ECCO (III): basic mechanisms of intestinal healing.
    Rieder F; Karrasch T; Ben-Horin S; Schirbel A; Ehehalt R; Wehkamp J; de Haar C; Velin D; Latella G; Scaldaferri F; Rogler G; Higgins P; Sans M
    J Crohns Colitis; 2012 Apr; 6(3):373-85. PubMed ID: 22405177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease.
    Lovisa S; Genovese G; Danese S
    J Crohns Colitis; 2019 Apr; 13(5):659-668. PubMed ID: 30520951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective Use of the Laboratory in the Management of Patients with Inflammatory Bowel Diseases.
    Ince MN; Elliott DE
    Gastroenterol Clin North Am; 2019 Jun; 48(2):237-258. PubMed ID: 31046973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic modulation during intestinal fibrosis.
    Bos S; Laukens D
    J Dig Dis; 2020 Jun; 21(6):319-325. PubMed ID: 32406133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of neutrophil migration into the gut by cytology of whole gut lavage fluid.
    Handy LM; Ghosh S; Ferguson A
    Eur J Gastroenterol Hepatol; 1995 Jan; 7(1):53-8. PubMed ID: 7866812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
    Szewczuk MR; Depew WT
    Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
    Katsanos KH; Vermeire S; Christodoulou DK; Riis L; Wolters F; Odes S; Freitas J; Hoie O; Beltrami M; Fornaciari G; Clofent J; Bodini P; Vatn M; Nunes PB; Moum B; Munkholm P; Limonard C; Stockbrugger R; Rutgeerts P; Tsianos EV;
    Digestion; 2007; 75(2-3):113-21. PubMed ID: 17598963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in Use of Endoscopy, Radiology, and Biomarkers to Monitor Inflammatory Bowel Diseases.
    Panes J; Jairath V; Levesque BG
    Gastroenterology; 2017 Feb; 152(2):362-373.e3. PubMed ID: 27751880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results from the 2nd Scientific Workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel disease.
    Peyrin-Biroulet L; Ferrante M; Magro F; Campbell S; Franchimont D; Fidder H; Strid H; Ardizzone S; Veereman-Wauters G; Chevaux JB; Allez M; Danese S; Sturm A;
    J Crohns Colitis; 2011 Oct; 5(5):477-83. PubMed ID: 21939925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of vasoactive intestinal peptide receptor 1 expression in inflammatory bowel disease.
    Yukawa T; Oshitani N; Yamagami H; Watanabe K; Higuchi K; Arakawa T
    Int J Mol Med; 2007 Aug; 20(2):161-7. PubMed ID: 17611633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.